South Korea
· Delayed Price · Currency is KRW DNA Link Statistics
Total Valuation
DNA Link has a market cap or net worth of KRW 84.09 billion. The enterprise value is 88.30 billion.
| Market Cap | 84.09B |
| Enterprise Value | 88.30B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DNA Link has 22.48 million shares outstanding. The number of shares has increased by 5.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 22.48M |
| Shares Change (YoY) | +5.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.48% |
| Owned by Institutions (%) | n/a |
| Float | 17.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.54 |
| PB Ratio | 2.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.72 |
| EV / Sales | 4.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.82 |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.30.
| Current Ratio | 0.92 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.20 |
| Interest Coverage | -17.08 |
Financial Efficiency
Return on equity (ROE) is -28.14% and return on invested capital (ROIC) is -13.19%.
| Return on Equity (ROE) | -28.14% |
| Return on Assets (ROA) | -10.00% |
| Return on Capital (ROIC) | -13.19% |
| Revenue Per Employee | 212.34M |
| Profits Per Employee | -77.12M |
| Employee Count | 90 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 3.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +9.57% |
| 50-Day Moving Average | 3,382.00 |
| 200-Day Moving Average | 3,081.78 |
| Relative Strength Index (RSI) | 56.71 |
| Average Volume (20 Days) | 112,876 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DNA Link had revenue of KRW 19.11 billion and -6.94 billion in losses. Loss per share was -383.49.
| Revenue | 19.11B |
| Gross Profit | 3.43B |
| Operating Income | -6.35B |
| Pretax Income | -6.94B |
| Net Income | -6.94B |
| EBITDA | -4.84B |
| EBIT | -6.35B |
| Loss Per Share | -383.49 |
Balance Sheet
The company has 2.93 billion in cash and 7.14 billion in debt, giving a net cash position of -4.21 billion or -187.32 per share.
| Cash & Cash Equivalents | 2.93B |
| Total Debt | 7.14B |
| Net Cash | -4.21B |
| Net Cash Per Share | -187.32 |
| Equity (Book Value) | 23.61B |
| Book Value Per Share | 1,263.41 |
| Working Capital | -1.09B |
Cash Flow
In the last 12 months, operating cash flow was -4.50 billion and capital expenditures -1.46 billion, giving a free cash flow of -5.96 billion.
| Operating Cash Flow | -4.50B |
| Capital Expenditures | -1.46B |
| Free Cash Flow | -5.96B |
| FCF Per Share | -264.95 |
Margins
Gross margin is 17.96%, with operating and profit margins of -33.23% and -36.32%.
| Gross Margin | 17.96% |
| Operating Margin | -33.23% |
| Pretax Margin | -36.32% |
| Profit Margin | -36.32% |
| EBITDA Margin | -25.31% |
| EBIT Margin | -33.23% |
| FCF Margin | -31.17% |
Dividends & Yields
DNA Link does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.07% |
| Shareholder Yield | -5.07% |
| Earnings Yield | -10.25% |
| FCF Yield | -7.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DNA Link has an Altman Z-Score of -0.75. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.75 |
| Piotroski F-Score | n/a |